During the past decade, Lukaskrankenhaus Neuss conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 2 clinical trials were completed, i.e. on average, 18.2% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 2 clinical trials were completed. i.e. 28.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Lukaskrankenhaus Neuss" #1 sponsor was "Biotronik AG" with 6 trials, followed by "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 4 trials sponsored, "ResMed" with 3 trials sponsored, "Abbott Medical Devices" with 2 trials sponsored and "Biotronik SE & Co. KG" with 2 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lukaskrankenhaus Neuss" #1 collaborator was "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator, "Amgen" with 1 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Australia New Zealand Gynaecological Oncology Group" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Lukaskrankenhaus Neuss" are "Coronary Artery Disease" (10 trials), "Heart Failure" (4 trials), "Lymphoma" (4 trials), "Congestive Heart Failure" (2 trials) and "Coronary Artery Stenosis" (2 trials). Many other conditions were trialed in "Lukaskrankenhaus Neuss" in a lesser frequency.

Most popular intervention types in "Lukaskrankenhaus Neuss" are "Device" (17 trials), "Drug" (9 trials), "Biological" (6 trials), "Radiation" (4 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (4 trials), "doxorubicin hydrochloride" (4 trials), "prednisone" (4 trials), "radiation therapy" (4 trials) and "vincristine sulfate" (4 trials). Other intervention names were less common.

The vast majority of trials in "Lukaskrankenhaus Neuss" are 31 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Lukaskrankenhaus Neuss". undefined are not yet recruiting, 7 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Lukaskrankenhaus Neuss, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Lukaskrankenhaus Neuss, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 10 trials that are defined as “Not Applicable".